2016
DOI: 10.1007/s00590-016-1826-3
|View full text |Cite
|
Sign up to set email alerts
|

Subacromial injection of autologous platelet-rich plasma versus corticosteroid for the treatment of symptomatic partial rotator cuff tears

Abstract: II.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
132
1
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 136 publications
(140 citation statements)
references
References 39 publications
5
132
1
2
Order By: Relevance
“…One large difference in methodology is that the majority of those enrolled in one-time single-site injections were compared to active interventions of enthesis saline, which has demonstrated some efficacy in the study of Bertrand et al, and subacromial corticosteroid injection, which has previously demonstrated efficacy in rotator cuff tendinopathy. 11,[24][25][26] Another methodologic difference is that patients included in one-time single-site injection studies tended to have milder baseline pain with lower pain intensity scores and improved baseline function with low SPADI scores and more active range of motion. Despite these methodologic differences, repeat multisite dextrose prolotherapy protocols demonstrated larger absolute improvements in VAS, SPADI, and range of motion.…”
Section: Discussionmentioning
confidence: 99%
“…One large difference in methodology is that the majority of those enrolled in one-time single-site injections were compared to active interventions of enthesis saline, which has demonstrated some efficacy in the study of Bertrand et al, and subacromial corticosteroid injection, which has previously demonstrated efficacy in rotator cuff tendinopathy. 11,[24][25][26] Another methodologic difference is that patients included in one-time single-site injection studies tended to have milder baseline pain with lower pain intensity scores and improved baseline function with low SPADI scores and more active range of motion. Despite these methodologic differences, repeat multisite dextrose prolotherapy protocols demonstrated larger absolute improvements in VAS, SPADI, and range of motion.…”
Section: Discussionmentioning
confidence: 99%
“…Rha et al 24 have applied PRP twice and demonstrated that the activity continued even at month six; however, their sample size was smaller. On the other hand, Shams et al 26 have administered a single dose of PRP; however, in month six, they detected that PRP activity did not continue. Furthermore, Randelli et al 25 have shown that PRP treatment was effective during arthroscopic repair in patients with full-thickness tears, while no long-term efficacy was detected.…”
Section: Discussionmentioning
confidence: 98%
“…[13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] The most common reasons for exclusion were review paper (53), non-tendinopathy (14), injection of active control (7; eg, whole blood, PRP) and non-randomised study (7). Several manuscripts were excluded from this review because they were superseded by papers from the same study with longer follow-up including de Vos et al 29 30 and Peerbooms et al 31 A flow diagram of study identification and selection is shown in figure 1.…”
Section: Study Selectionmentioning
confidence: 99%